top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anthony Cerami : a life in translational medicine / / Conrad Keating
Anthony Cerami : a life in translational medicine / / Conrad Keating
Autore Keating Conrad
Pubbl/distr/stampa New Brunswick : , : Rutgers University Press, , [2021]
Descrizione fisica 1 online resource (219 pages)
Disciplina 610.72
Soggetto topico Medicine - Research
Medical scientists
Drugs - Design
Biochemists
Soggetto non controllato Anthony Cerami, Translational Medicine, Medicine, therapeutics, Rockefeller University, biochemistry, malaria vaccine, tropical diseases, Africa, immunology, metabolic diseases, diabetes, medical research, Ph.D., pathogenesis, Harvard, Crohn's disease
ISBN 1-9788-0142-4
1-9788-0144-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Introduction -- Hard work -- The Rockefeller effect -- The shaping of a scientific mind -- The Rockefeller University and the broad horizon -- Diabetes: The creation of the hemoglobin arc test -- Glucose, aging, the cross-linking of biology and business -- The conceptual breakthrough -- Cachectin -- Tumor necrosis factor -- Leaving the Rockefeller University: The end of the dream -- Philanthropy goes awry -- Translation in transition -- Anti-TNF therapy: Changing the pharmaceutical landscape -- Taking on big pharma.
Record Nr. UNINA-9910794539803321
Keating Conrad  
New Brunswick : , : Rutgers University Press, , [2021]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Anthony Cerami : a life in translational medicine / / Conrad Keating
Anthony Cerami : a life in translational medicine / / Conrad Keating
Autore Keating Conrad
Edizione [1st ed.]
Pubbl/distr/stampa New Brunswick : , : Rutgers University Press, , [2021]
Descrizione fisica 1 online resource (219 pages)
Disciplina 610.72
Soggetto topico Medicine - Research
Medical scientists
Drugs - Design
Biochemists
Soggetto non controllato Anthony Cerami, Translational Medicine, Medicine, therapeutics, Rockefeller University, biochemistry, malaria vaccine, tropical diseases, Africa, immunology, metabolic diseases, diabetes, medical research, Ph.D., pathogenesis, Harvard, Crohn's disease
ISBN 1-9788-0142-4
1-9788-0144-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Introduction -- Hard work -- The Rockefeller effect -- The shaping of a scientific mind -- The Rockefeller University and the broad horizon -- Diabetes: The creation of the hemoglobin arc test -- Glucose, aging, the cross-linking of biology and business -- The conceptual breakthrough -- Cachectin -- Tumor necrosis factor -- Leaving the Rockefeller University: The end of the dream -- Philanthropy goes awry -- Translation in transition -- Anti-TNF therapy: Changing the pharmaceutical landscape -- Taking on big pharma.
Record Nr. UNINA-9910813351403321
Keating Conrad  
New Brunswick : , : Rutgers University Press, , [2021]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Anticancer drugs : design, delivery and pharmacology / / Peter Spencer and Walter Holt, editors
Anticancer drugs : design, delivery and pharmacology / / Peter Spencer and Walter Holt, editors
Pubbl/distr/stampa New York : , : Nova Biomedical Books, , 2009
Descrizione fisica 1 online resource (xi, 271 pages) : illustrations
Disciplina 615/.798
Altri autori (Persone) HoltWalter
SpencerPeter <1964->
Collana Cancer etiology, diagnosis and treatments
Soggetto topico Antineoplastic agents
Antimitotic agents
Cancer - Chemotherapy
Drugs - Design
ISBN 1-60876-629-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Micro- and nano-particulate drug delivery systems for cancer treatment / José L. Arias -- Geldanamycin derivatives as promising anticancer drugs : therapy via Hsp90 inhibition / Alexander E. Kabakov -- Synergistic antitumor activity of metronomic dosing chemotherapy in combination with liposomal anticancer drug / Tatsuhiro Ishida, Hiroshi Kiwada -- Organotin polyethers as anticancer drugs / Charles E. Carraher, Michael R. Roner, Girish Barot -- Studies on anti-cancer agents : phenolic compounds and their pharmacological activity / Maria Dolors Pujol, Isabel Sánchez -- Design of novel anticancer drugs utilizing busulfan for optimizing pharmacological properties and pattern recognition techniques for elucidation of clinical efficacy / Ronald Bartzatt -- Analysis of associations among novel property descriptors and their capacity in determining clinical efficacy by utilizing pattern recognition technigues / Ronald Bartzatt -- Insights into the mode of action of bioreductive ruthenium cytotoxins / Erwin Reisner -- Marina crystal minerals(MCM) induce apoptosis of human metastatic breast cancer MDA-MB-231 cells in vitro / Mamdooh Ghoneum, Takeshi Ogura, Sastry Gollapudi.
Record Nr. UNINA-9910779518403321
New York : , : Nova Biomedical Books, , 2009
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Anticancer drugs : design, delivery and pharmacology / / Peter Spencer and Walter Holt, editors
Anticancer drugs : design, delivery and pharmacology / / Peter Spencer and Walter Holt, editors
Edizione [1st ed.]
Pubbl/distr/stampa New York : , : Nova Biomedical Books, , 2009
Descrizione fisica 1 online resource (xi, 271 pages) : illustrations
Disciplina 615/.798
Altri autori (Persone) HoltWalter
SpencerPeter <1964->
Collana Cancer etiology, diagnosis and treatments
Soggetto topico Antineoplastic agents
Antimitotic agents
Cancer - Chemotherapy
Drugs - Design
ISBN 1-60876-629-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Micro- and nano-particulate drug delivery systems for cancer treatment / José L. Arias -- Geldanamycin derivatives as promising anticancer drugs : therapy via Hsp90 inhibition / Alexander E. Kabakov -- Synergistic antitumor activity of metronomic dosing chemotherapy in combination with liposomal anticancer drug / Tatsuhiro Ishida, Hiroshi Kiwada -- Organotin polyethers as anticancer drugs / Charles E. Carraher, Michael R. Roner, Girish Barot -- Studies on anti-cancer agents : phenolic compounds and their pharmacological activity / Maria Dolors Pujol, Isabel Sánchez -- Design of novel anticancer drugs utilizing busulfan for optimizing pharmacological properties and pattern recognition techniques for elucidation of clinical efficacy / Ronald Bartzatt -- Analysis of associations among novel property descriptors and their capacity in determining clinical efficacy by utilizing pattern recognition technigues / Ronald Bartzatt -- Insights into the mode of action of bioreductive ruthenium cytotoxins / Erwin Reisner -- Marina crystal minerals(MCM) induce apoptosis of human metastatic breast cancer MDA-MB-231 cells in vitro / Mamdooh Ghoneum, Takeshi Ogura, Sastry Gollapudi.
Record Nr. UNINA-9910824158703321
New York : , : Nova Biomedical Books, , 2009
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antimicrobial drug discovery [[electronic resource] ] : emerging strategies / / edited by George Tegos and Eleftherios Mylonakis
Antimicrobial drug discovery [[electronic resource] ] : emerging strategies / / edited by George Tegos and Eleftherios Mylonakis
Pubbl/distr/stampa Wallingford, Oxfordshire, U.K., : CABI, 2012
Descrizione fisica 1 online resource (369 p.)
Disciplina 615.792
Altri autori (Persone) TegosGeorge
MylonakisEleftherios
Collana Advances in Molecular and Cellular Microbiology
Advances in molecular and cellular microbiology
Soggetto topico Anti-infective agents
Drugs - Design
Diseases - Animal models
High throughput screening - Methodology
Photosensitizing compounds
Pharmacology
ISBN 1-283-67084-4
1-78064-031-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Emerging discovery strategies : an evolving necessity / Anthony R. Ball and George P. Tegos -- The antibiotic crisis / Arnold L. Demain and Jaroslav Spizek -- Structure, genetic regulation, physiology and function of the AcrAB-TolC efflux pump of escerichia coli and salmonella / Leonard Amaral ... [et al.] -- Small molecule efflux pump inhibitors from natural products as a potential source of antimicrobial agents / Sanjay M. Jachak ... [et al.] -- Fungal efflux-mediated resistance : from targets to inhibitors / Brian C. Monk ... [et al.] -- Vacuolar ATPase (V-ATPase) : a model proton pump for antifungal drug discovery -- Karlett J Parra -- Drug tolerance, persister cells and drug discovery / Kim Lewis -- Inhibition of quorum sensing as a novel antimicrobial strategy -- Gilles Brackman, Hans J. Nelis and Tom Coenye -- Filamentous temperature-sensitive mutant Z (FtsZ) protein as an antibacterial target / Jaroslaw M. Boberek ... [et al.] -- Lysostaphin : a silver bullet for staph / John F. Kokai-Kun -- Strategies to identify modified ribosomally synthesized antimicrobials -- Alan J. Marsh ... [et al.] -- QSAR based discovery of antimicrobial peptides active against multidrug resistant bacteria / Christopher D. Fjell ... [et al.] -- Acetyl-CoA carboxylase as a target for antibacterial development / Grover L. Waldrop -- Underexploited targets in LPS biogenenesis for the design of antibacterials / Laura Cipolla ... [et al.] -- Predicting and dissecting biomolecular interactions by information-driven docking / Panagiotis Kastritsis & Alexandre M.J.J Bonvin -- Anti-fungals and anti-fungal drug discovery / Richard Calderone ... [et al.] -- Pathosystematic studies and the rational design of antifungal interventions / Elaine M Bignell and Darius Armstrong-James -- In vivo high-throughput antimicrobial discovery screens utilizing caenorhabditis elegans as an alternative host / Jeffrey J. Coleman and Eleftherios Mylonakis -- Drosophila melanogaster as a versatile model for discovery of drugs effective against human microbe-induced infection and pathology / Yiorgos Apidianakis and Dimitrios P. Kontoyiannis -- Antimicrobial photosensitizers - harnessing the power of light to treat infections / Sulbha K Sharma, Tianhong Dai and Michael R Hamblin -- Nanoparticle platforms for antimicrobial therapy / David Trofa, Joshua D. Nosanchuk -- Antimicrobial activity of carbon nanotubes / Shaobin Liu, Yuan Chen.
Record Nr. UNINA-9910626114203321
Wallingford, Oxfordshire, U.K., : CABI, 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antimicrobial peptides : discovery, design and novel therapeutic strategies / / edited by Guangshun Wang
Antimicrobial peptides : discovery, design and novel therapeutic strategies / / edited by Guangshun Wang
Edizione [Second edition.]
Pubbl/distr/stampa Oxfordshire, England ; ; Boston, Massachusetts : , : CABI, , [2017]
Descrizione fisica 1 online resource (xvii, 268 pages) : illustrations
Disciplina 612.015
Soggetto topico Peptide antibiotics
Drugs - Design
Soggetto genere / forma Electronic books.
ISBN 1-78639-041-8
1-78639-040-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910480831003321
Oxfordshire, England ; ; Boston, Massachusetts : , : CABI, , [2017]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antimicrobial peptides : discovery, design and novel therapeutic strategies / / edited by Guangshun Wang
Antimicrobial peptides : discovery, design and novel therapeutic strategies / / edited by Guangshun Wang
Edizione [Second edition.]
Pubbl/distr/stampa Oxfordshire, England ; ; Boston, Massachusetts : , : CABI, , [2017]
Descrizione fisica 1 online resource (xvii, 268 pages) : illustrations
Disciplina 612.015
Soggetto topico Peptide antibiotics
Drugs - Design
ISBN 1-78639-041-8
1-78639-040-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Discovery, classification and functional diversity of antimicrobial peptides / Guangshun Wang -- Structural and functional diversity of cathelicidins / Alessandro Tossi, Barbara Skerlavaj, Francesca D'Este and Renato Gennaro -- Disulfide-linked defensins and their therapeutic potential -- Monique von Hoek -- Lantibiotics : bioengineering and applications / Brian Healy and Paul Cotter -- Discovery of novel antimicrobial peptides using combinatorial chemistry and high-throughput screening / Charles G. Starr and William C. Wimley -- Prediction and design of antimicrobial peptides: methods and applications to genomes and proteomes / Guangshun Wang -- Antimicrobial peptides, multiple mechanisms against a variety of targets / Li-av Segev-Zarko, Maria Luisa Mangoni and Yechiel Shai -- Microbial membranes and the action of antimicrobial peptides / José Carlos Bozelli Junior, Shirley Schreier and Richard Epand -- Non-membrane-targeting amps, novel therapeutic opportunities? / Marco Scocchi, Mario Mardirossian, Giulia Runti and Monica Benincasa -- Structural insight into the mechanism of action of antimicrobial peptides and structure-based design / Guangshun Wang -- Synergy of antimicrobial peptides / Moswabar H. Chowdhury, Gill Diamond and Lisa Kathleen Ryan -- Surface immobilization of antimicrobial peptides to prevent biofilm formation / Biswajit Mishra, Scott Reiling and Guangshun Wang -- Sustained delivery of cathelicidin antimicrobial peptide-inducing compounds to minimize infection and enhance wound healing / Jingwei Xie, Gitali Ganguli-Indra,, Arup K. Indra and Adrian Gombart -- Immunomodulatory activities of cationic host defense peptides and novel therapeutic strategies / Kelli C. Wuerth and Robert Hancock.
Record Nr. UNINA-9910529502403321
Oxfordshire, England ; ; Boston, Massachusetts : , : CABI, , [2017]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Applied biophysics for drug discovery / / edited by Donald Huddler, Edward R. Zartler
Applied biophysics for drug discovery / / edited by Donald Huddler, Edward R. Zartler
Pubbl/distr/stampa Hoboken, New Jersey ; ; Chichester, West Sussex, England : , : Wiley, , 2017
Descrizione fisica 1 online resource (292 pages) : illustrations, graphs
Disciplina 615.19
Soggetto topico Drug development
Drugs - Design
Biophysics
Soggetto genere / forma Electronic books.
ISBN 1-119-09950-1
1-119-09949-8
1-119-09951-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910270886603321
Hoboken, New Jersey ; ; Chichester, West Sussex, England : , : Wiley, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Applied biophysics for drug discovery / / edited by Donald Huddler, Edward R. Zartler
Applied biophysics for drug discovery / / edited by Donald Huddler, Edward R. Zartler
Pubbl/distr/stampa Hoboken, New Jersey ; ; Chichester, West Sussex, England : , : Wiley, , 2017
Descrizione fisica 1 online resource (292 pages) : illustrations, graphs
Disciplina 615.19
Soggetto topico Drug development
Drugs - Design
Biophysics
ISBN 1-119-09950-1
1-119-09949-8
1-119-09951-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910831078103321
Hoboken, New Jersey ; ; Chichester, West Sussex, England : , : Wiley, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The art of drug synthesis / / edited by Douglas S. Johnson, Jie Jack Li
The art of drug synthesis / / edited by Douglas S. Johnson, Jie Jack Li
Edizione [1st ed.]
Pubbl/distr/stampa Hoboken, N.J. : , : Wiley-Interscience, , 2007
Descrizione fisica 1 online resource (xv, 276 pages) : illustrations
Disciplina 615.19
615/.19
Altri autori (Persone) JohnsonDouglas S <1968-> (Douglas Scott)
LiJie Jack
Collana Wiley Series on Drug Synthesis
Soggetto topico Drugs - Design
Pharmaceutical chemistry
ISBN 1-118-67846-X
1-280-91677-X
9786610916771
0-470-13497-6
0-470-13496-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto THE ART OF DRUG SYNTHESIS; CONTENTS; Foreword; Preface; Contributors; 1 THE ROLE OF MEDICINAL CHEMISTRY IN DRUG DISCOVERY; 1.1 Introduction; 1.2 Hurdles in the Drug Discovery Process; 1.3 The Tools of Medicinal Chemistry; 1.3.1 In Silico Modeling; 1.3.2 Structure-Based Drug Design (SBDD); 1.4 The Role of Synthetic Chemistry in Drug Discovery; References; 2 PROCESS RESEARCH: HOW MUCH? HOW SOON?; 2.1 Introduction; 2.2 Considerations for Successful Scale-up to Tox Batches and Phase I Material; 2.3 Considerations for Phase 2 Material and Beyond; 2.3.1 Reagent Selection; 2.3.2 Solvent Selection
2.3.3 Unit Operations; 2.3.4 Developing Simple, Effective, Efficient Work-ups and Isolations; 2.3.5 The Importance of Physical States; 2.3.6 Route Design and Process Optimization to Minimize COG; 2.4 Summary; References; I CANCER AND INFECTIOUS DISEASES; 3 AROMATASE INHIBITORS FOR BREAST CANCER: EXEMESTANE (AROMASIN®), ANASTROZOLE (ARIMIDEX®), AND LETROZOLE (FEMARA®); 3.1 Introduction; 3.2 Synthesis of Exemestane; 3.3 Synthesis of Anastrozole; 3.4 Synthesis of Letrozole; References
4 QUINOLONE ANTIBIOTICS: LEVOFLOXACIN (LEVAQUIN®), MOXIFLOXACIN (AVELOX®), GEMIFLOXACIN (FACTIVE®), AND GARENOXACIN (T-3811)4.1 Introduction; 4.1.1 Mechanism of Action; 4.1.2 Modes of Resistance; 4.1.3 Structure-Activity Relationship (SAR) and Structure-Toxicity Relationship (STR); 4.1.4 Pharmacokinetics; 4.1.5 Synthetic Approaches; 4.2 Levofloxacin; 4.3 Moxifloxacin; 4.4 Gemifloxacin; 4.5 Garenoxacin (T-3811): A Promising Clinical Candidate; References; 5 TRIAZOLE ANTIFUNGALS: ITRACONAZOLE (SPORANOX®), FLUCONAZOLE (DIFLUCAN®), VORICONAZOLE (VFEND®), AND FOSFLUCONAZOLE (PRODIF®)
5.1 Introduction; 5.2 Synthesis of Itraconazole; 5.3 Synthesis of Fluconazole; 5.4 Synthesis of Voriconazole; 5.5 Synthesis of Fosfluconazole; References; 6 NON-NUCLEOSIDE HIV REVERSE TRANSCRIPTASE INHIBITORS; 6.1 Introduction; 6.2 Synthesis of Nevirapine; 6.3 Synthesis of Efavirenz; 6.4 Synthesis of Delavirdine Mesylate; References; 7 NEURAMINIDASE INHIBITORS FOR INFLUENZA: OSELTAMIVIR PHOSPHATE (TAMIFLU®) AND ZANAMIVIR (RELENZA®); 7.1 Introduction; 7.1.1 Relenza; 7.1.2 Tamiflu; 7.2 Synthesis of Oseltamivir Phosphate (Tamiflu®); 7.3 Synthesis of Zanamivir (Relenza®); References
II CARDIOVASCULAR AND METABOLIC DISEASES; 8 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) AGONISTS FOR TYPE 2 DIABETES; 8.1 Introduction; 8.1.1 Insulin; 8.1.2 Sulfonylurea Drugs; 8.1.3 Meglitinides; 8.1.4 Biguanides; 8.1.5 Alpha-Glucosidase Inhibitors; 8.1.6 Thiazolidinediones; 8.2 Synthesis of Rosiglitazone; 8.3 Synthesis of Pioglitazone; 8.4 Synthesis of Muraglitazar; References; 9 ANGIOTENSIN AT(1) ANTAGONISTS FOR HYPERTENSION; 9.1 Introduction; 9.2 Losartan Potassium; 9.2.1 Introduction to Losartan Potassium; 9.2.2 Synthesis of Losartan Potassium; 9.3 Valsartan; 9.3.1 Introduction to Valsartan
Record Nr. UNINA-9910143402603321
Hoboken, N.J. : , : Wiley-Interscience, , 2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui